Media headlines about Intermolecular (NASDAQ:IMI) have trended somewhat positive this week, Accern Sentiment reports. The research group scores the sentiment of press coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Intermolecular earned a news sentiment score of 0.05 on Accern’s scale. Accern also gave media headlines about the semiconductor company an impact score of 45.3979560672864 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

Separately, ValuEngine upgraded Intermolecular from a “strong sell” rating to a “sell” rating in a report on Monday, August 7th.

Intermolecular (NASDAQ:IMI) traded down 0.98% during trading on Tuesday, hitting $1.01. The stock had a trading volume of 12,416 shares. The firm’s 50 day moving average is $0.91 and its 200 day moving average is $0.91. Intermolecular has a 1-year low of $0.78 and a 1-year high of $1.20. The firm’s market cap is $50.05 million.

In other news, major shareholder Lloyd I. Miller III bought 80,000 shares of the stock in a transaction on Thursday, June 22nd. The shares were purchased at an average price of $0.88 per share, for a total transaction of $70,400.00. Following the completion of the purchase, the insider now directly owns 70,368 shares of the company’s stock, valued at approximately $61,923.84. The purchase was disclosed in a filing with the SEC, which is available through this link. Also, major shareholder Lloyd I. Miller III bought 34,109 shares of the stock in a transaction on Friday, September 1st. The stock was purchased at an average price of $0.86 per share, for a total transaction of $29,333.74. Following the purchase, the insider now directly owns 70,368 shares of the company’s stock, valued at $60,516.48. The disclosure for this purchase can be found here. Insiders acquired 118,930 shares of company stock worth $103,880 in the last 90 days. Corporate insiders own 45.40% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Intermolecular (IMI) Earning Somewhat Positive Media Coverage, Study Finds” was published by Daily Political and is the sole property of of Daily Political. If you are accessing this news story on another site, it was copied illegally and republished in violation of United States & international copyright law. The original version of this news story can be viewed at https://www.dailypolitical.com/2017/09/19/intermolecular-imi-earning-somewhat-positive-media-coverage-study-finds.html.

About Intermolecular

Intermolecular, Inc provides thin film solutions. The Company’s high productivity combinatorial (HPC) platform, which consists of its tempus processing tools, its automated characterization methods, and its Informatics analysis software, is purpose-built for research and development (R&D) using combinatorial process systems.

Insider Buying and Selling by Quarter for Intermolecular (NASDAQ:IMI)

Receive News & Ratings for Intermolecular Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intermolecular Inc. and related companies with MarketBeat.com's FREE daily email newsletter.